Metaxalone - Isotope Labelled Standards
References
FAQ's
References
- 5-(polysubstituted phenoxymethyl)-2-oxazolidones, GB888594A, Jan 31, 1962, H. Robins Co., Inc. (https://www.lens.org/lens/search/patent/list?q=GB888594)
- Trivedi, Rakshit Kanubhai; Patel, Mukesh C., Development of a stability-indicating RP-UPLC method for rapid determination of metaxalone and its degradation products in solid oral dosage form, Scientia Pharmaceutica, Volume: 80, Issue: 2, Pages: 353-366, 2012 DOI: (10.3797/scipharm.1112-08)
Frequently Asked Questions
What is the analytical method to analyze Metaxalone from its degradation products?
RP-HPLC–UV method helps analyze Metaxalone from its degradation products.
What are the possible reasons for the formation of Metaxalone impurities?
Starting materials, reagents, unreacted catalysts during synthesis, and poor storage conditions may form Metaxalone impurities.
Why is it necessary to remove Metaxalone impurities from the drug?
Metaxalone impurities can affect drug safety and quality and pose health risks, so it is necessary to remove them from the drug.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.